35 min listen
An update from biopharma’s hotspot
ratings:
Length:
27 minutes
Released:
Dec 2, 2020
Format:
Podcast episode
Description
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, Part of Clarivate talks to Bob Coughlin, president and CEO of the Massachusetts Biotechnology Council. Bob provides insights from what is unarguably the world’s number one biopharma hotspot. Bob and Mike discuss how the industry has collaborated to counter the most immediate issues the COVID-19 pandemic has raised and how these could inform the future of biopharma. Bob also talks passionately about how partnering with patient groups is key to patient centricity to truly understand the real unmet patient need. Hosted on Acast. See acast.com/privacy for more information.
Released:
Dec 2, 2020
Format:
Podcast episode
Titles in the series (48)
Pivoting a product launch during the pandemic by Conversations in Healthcare